Search
0
Items
Select
Search
MENU
Select

Rimonabant

Cat. No. CB-020

Structure:

5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide

Other Names:

SR 141716A, Accomplia

Activity:

CB1 receptor inverse agonist
Price Qty
10 mg    £ 85.00

Rimonabant is a selective CB1 receptor inverse agonist with a Ki of 1.8 nM and no activity at CB2 receptors.  Rimonobant also acts as a μ-opioid receptor antagonist with a Ki of 652 nM.  Rimonabant reduces the overactivity of the endocannabinoid system, improving lipid and glucose metabolism and regulating energy balance.  In animal sudies, it reduces food intake and body weight in orally dosed non-obese Wistar rats and has a positive role in reducing hunger, caloric intake, and body weight, and in increasing satiety.  In humans, rimonabant initially appeared to be effective for treatment of obesity and smoking cessation but was withdrawn from the market due to having the potential to cause severe psychiatric side effects.

Rinaldi-Carmona et al (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56(23-24) 1941 PMID: 7776817

Colombo et al (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63(8) PL113-7 PMID: 9718088

Boyd and Fremming (2005) Rimonabant--a selective CB1 antagonist. Ann Pharmacother. 39(4) 684 PMID: 15755787

Seely et al (2012) AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies. Neuropharmacology 63(5) 905 PMID: 22771770

Bosquez-Berger et al (2023) A. Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB1 Receptor Antagonists after the Fall. Drugs Drug Candidates 2 689 https://doi.org/10.3390/ddc2030035


Related areas

All small molecules >
All cannabinoid receptor modulators >
All μ opioid receptor modulators >
All neuroscience research categories >
All appetite regulation research categories >


Technical Data

Structure 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide
CAS Number 168273-06-1
Molecular Weight 463.8
Formula C22H21Cl3N4O

Solubility and Storage

Solubility Soluble in DMSO to 20 mg/ml or ethanol to 20 mg/ml
Appearance White solid
Storage Store dry, frozen and in the dark

Batch Specific Data

Purity > 98% by hplc, NMR conforms

Contact Information

To place an order, or for customer services, order processing or technical support please contact us on:

UK, Europe and RoW
Tel: (+44) 01392 422205
Fax: (+44) 01392 279510
info@iscabiochemicals.com

USA and Canada

Tel: 610-994-1134

Toll Free: 855-FOCUS21 (855-362-8721)

Fax: 610-465-9100

sales@focusbiomolecules.com 


France

CliniSciences
Tel : +33 9 77 40 09 09
Fax :  +33 9 77 40 10 11
Orders and customer support : info@clinisciences.com


Germany, Switzerland, Austria

BIOZOL Diagnostics 

Tel: +49 (089) 3799 666-6

Fax: +49 (089) 3799 666-99
Orders, Technical and Customer support: info@biozol.de


Italy
Labospace
Tel: +39 02 35980841
Fax +39 02 359808004
Orders: info@labospace.com


Spain and Portugal
Abyntek Biopharma
Tel: +34 94 404 80 80

Fax: +34 94 404 80 81
Orders: info@abyntek.com


China

BIOHUB INTERNATIONAL 

上海起发实验试剂有限公司

Tel: +86-15921799099

Tel: +86-021-50724187

Fax: +86-021-50724961

Orders: sale3@78bio.com

India
BTL Biotechno Labs Pvt Ltd
Tel: +91-8860924629
07291852429
Orders, Technical and Customer support: info@biotechnolabs.com


Japan

Namiki Shoji Co.
Tel:+81-050-5527-9850
Fax:+81-3-3352-2196
email:  globalbusiness1@namiki-s.co.jp


All distributors >